SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-23-007287
Filing Date
2023-04-28
Accepted
2023-04-28 16:20:24
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS ganx-20221231xars.pdf ARS 1950385
  Complete submission text file 0001558370-23-007287.txt   2687749
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40237 | Film No.: 23866630
SIC: 2834 Pharmaceutical Preparations